FDA.reportPublic FDA data

galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule

RxCUI
860715
RxNorm name
galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule
Display name
galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule
Full name
galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Galantamine HydrobromideGALANTAMINE HYDROBROMIDEBryant Ranch Prepackdb5b6c1e-449b-413f-b0cc-ca2133aa49862024-08-12Warnings, Adverse reactionsExact identifier
rxcui: 860715
Galantamine HydrobromideGALANTAMINE HYDROBROMIDEBryant Ranch Prepackc44108aa-bf20-4d45-b36f-d117320a675b2024-04-08Warnings, Adverse reactionsExact identifier
rxcui: 860715
GalantamineGALANTAMINEAurobindo Pharma Limitedd0b75970-8d3d-408b-9e17-9cbad0f776b12024-01-30Warnings, Adverse reactionsExact identifier
rxcui: 860715
Galantamine HydrobromideGALANTAMINE HYDROBROMIDESun Pharmaceutical Industries, Inc.d1697161-ebe8-42b0-83e7-c9de4412546c2023-10-26Warnings, Adverse reactionsExact identifier
rxcui: 860715

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
db5b6c1e-449b-413f-b0cc-ca2133aa4986galantamine HBr 8 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 8 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule [SY]3106These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120240812
c44108aa-bf20-4d45-b36f-d117320a675bgalantamine HBr 8 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 8 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule [SY]3101These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120240408
d1697161-ebe8-42b0-83e7-c9de4412546cgalantamine HBr 8 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 8 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule [SY]317These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120231026
d0b75970-8d3d-408b-9e17-9cbad0f776b1galantamine HBr 8 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 8 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule [SY]311These highlights do not include all the information needed to use GALANTAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE EXTENDED-RELEASE CAPSULES. GALANTAMINE extended-release capsules, for oral use Initial U.S. Approval: 200120240130